OCBC Investment Research (OIR)

Broker's Calls

OCBC Investment Research initiates ‘buy’ on PropNex with TP of 91 cents

Analyst Donovan Tan believes the negative sentiment towards the counter, which is largely due to the overhang of weak project launches, will improve.
Dyna-Mac shareholders should ‘accept’ Hanwha’s final offer, says Maybank - THE EDGE SINGAPORE

Broker's Calls

Dyna-Mac shareholders should ‘accept’ Hanwha’s final offer, says Maybank

“We believe that this represents a fair exit price for shareholders to realise their investment and reinvest into other under-valued counters,” says analyst Jarick Seet.

Broker's Calls

UOB’s share price will see support from ‘compelling’ yield, says OCBC Investment Research

OCBC Investment Research strategist Carmen Lee has kept her “hold” call with an unchanged fair value estimate of $33.50.
Should investors still buy DBS shares? - THE EDGE SINGAPORE

Banking & finance

Should investors still buy DBS shares?

OCBC strategist Carmen Lee sees that DBS's 'attractive' dividend yield of 5.5% will continue to support its share price.

Broker's Calls

OCBC downgrades Suntec REIT to ‘sell’ with higher TP of $1.19

Suntec REIT historically traded at a 10Y average forward distribution yield of 5.7%, based on the team's estimates.
Cromwell European REIT's high-quality assets and diversified tenant mix a factor for OCBC initiating 'buy' - THE EDGE SINGAPORE

Broker's Calls

Cromwell European REIT's high-quality assets and diversified tenant mix a factor for OCBC initiating 'buy'

The brokerage has given the REIT a fair value estimate of EUR1.87.

Broker's Calls

Analysts view ION deal positively for CICT; recommends unitholders to subscribe for preferential offering

RHB is “neutral” on the deal, noting that the pricing is “slightly on the higher end”.
S-REITs at ‘long-awaited turning point’, says OCBC Investment Research - THE EDGE SINGAPORE

Broker's Calls

S-REITs at ‘long-awaited turning point’, says OCBC Investment Research

The team has named FLCT, MINT, CLAS, CLAR and PLife REIT as its top picks.

Broker's Calls

Analysts mostly raise SGX’s target price estimates after FY2024 results

The analysts' target prices range from $10.20 to $10.80.
×